- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有48家主力机构披露2026-06-30报告期持股数据，持仓量总计4.68亿股，占流通A股81.89%
- 波段诊断：
-
技术面诊股
诊断结果：6.5技术面打败了64%的股票
技术面评分前10的股票
近期的平均成本为20.12元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为20.12元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"20.12","date":1788249370,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，接近行业平均水平。
[{"date":"2026.09.02","stock":"-1.08","trade":"-1.51","ind":"-1.88"},{"date":"2026.09.01","stock":"0.99","trade":"1.64","ind":"-1.02"},{"date":"2026.08.31","stock":"-1.52","trade":"-1.74","ind":"0.44"},{"date":"2026.08.28","stock":"0.74","trade":"0.09","ind":"-0.68"},{"date":"2026.08.27","stock":"0.15","trade":"1.05","ind":"1.50"},{"date":"2026.08.26","stock":"0.90","trade":"0.81","ind":"0.69"},{"date":"2026.08.25","stock":"1.82","trade":"2.69","ind":"-0.35"},{"date":"2026.08.24","stock":"-0.65","trade":"-1.70","ind":"-2.13"},{"date":"2026.08.21","stock":"-3.92","trade":"-3.27","ind":"0.87"},{"date":"2026.08.20","stock":"2.99","trade":"2.42","ind":"0.59"},{"date":"2026.08.19","stock":"-1.33","trade":"-1.50","ind":"-5.01"},{"date":"2026.08.18","stock":"-1.07","trade":"-1.04","ind":"-0.56"},{"date":"2026.08.17","stock":"-0.10","trade":"0.49","ind":"2.44"},{"date":"2026.08.14","stock":"-1.44","trade":"-0.81","ind":"0.45"},{"date":"2026.08.13","stock":"1.36","trade":"1.59","ind":"-0.87"},{"date":"2026.08.12","stock":"-0.39","trade":"0.14","ind":"1.09"},{"date":"2026.08.11","stock":"-0.72","trade":"0.34","ind":"-0.40"},{"date":"2026.08.10","stock":"-0.71","trade":"0.39","ind":"0.04"},{"date":"2026.08.07","stock":"2.74","trade":"2.10","ind":"1.42"},{"date":"2026.08.06","stock":"-0.87","trade":"0.32","ind":"-0.24"},{"date":"2026.08.05","stock":"-1.25","trade":"-0.59","ind":"1.86"}]
奇正藏药,深证成指,中药指数
压力支撑
该股压力位为20.17元，支撑位为19.95元。
[{"text":"\u538b\u529b\u4f4d","value":"20.17","date":1788278400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"19.95","date":1788278400,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.7资金面打败了30%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：09月02日 16:54
| 机构今日流向(万元) | -2103.36 | 机构5日流向(万元) | -5560.88 |
| 机构10日流向(万元) | -9527.34 | 机构20日流向(万元) | -18820.59 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少355.31万股，其中基金净减仓6家，主力净增仓15家，暂未发现中长期投资价值。
截止2026-06-30，共48家主力机构（基金44家，一般法人3家，QFII1家），持仓量总计46760.44万股，占流通A股81.89%
其中，基金持仓与2025-12-31相比：
增仓：5家 ，增持 16.86万股
减仓：11家 ，减持 217.58万股
新出现在主力名单中：29家 ，持有81.37万股
从主力名单中消失：14家 ，原持有68.2万股
其中，基金持仓与2025-12-31相比：
增仓：5家 ，增持 16.86万股
减仓：11家 ，减持 217.58万股
新出现在主力名单中：29家 ，持有81.37万股
从主力名单中消失：14家 ，原持有68.2万股
消息面诊股
诊断结果：6.3消息面打败了77%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 奇正藏药：9月1日获融资买入203.27万元
2026-09-02 - 奇正藏药：8月31日获融资买入219.40万元
2026-09-01 - 奇正藏药：8月28日获融资买入382.22万元
2026-08-31 - 奇正藏药：8月27日获融资买入152.03万元
2026-08-28 - 奇正藏药：8月26日获融资买入288.68万元
2026-08-27 - 奇正藏药：核心产品消痛贴膏上半年营收7.24亿元，
2026-08-26 - 奇正藏药：上半年营收下滑系行业政策与主动推进业务、
2026-08-26 - 集采击穿利润空间， 中药板块站上“换季”拐点
2026-08-26 - 奇正藏药：8月25日获融资买入170.90万元
2026-08-26 - 奇正藏药发布2026年半年度报告 全产业链核心能力
2026-08-25
消息列表
| 利好 | 分红转增 | 10派2.30元(含税) | 2026-08-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-08-14 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-07-01 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-06-13 |
| 一般消息 | 重大事项 | 关联交易 | 2026-06-06 |
| 一般消息 | 募资投向 | 2026-06-01 | |
| 利好 | 分红转增 | 10派4.1元(含税) | 2026-04-24 |
| 一般消息 | 募资投向 | 公司出售资产 | 2026-04-15 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-08 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-03-26 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-27 |
| 一般消息 | 高管变动 | 委员会调整 | 2025-10-27 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-09-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：7.0行业面打败了82%的股票
中药行业最新资金流向
近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑赢大盘。
[{"date":"2026.09.02","price":"-1.88","value":"1.64"},{"date":"2026.09.01","price":"-1.02","value":"-1.74"},{"date":"2026.08.31","price":"0.44","value":"0.09"},{"date":"2026.08.28","price":"-0.68","value":"1.05"},{"date":"2026.08.27","price":"1.50","value":"0.81"},{"date":"2026.08.26","price":"0.69","value":"2.69"},{"date":"2026.08.25","price":"-0.35","value":"-1.70"},{"date":"2026.08.24","price":"-2.13","value":"-3.27"},{"date":"2026.08.21","price":"0.87","value":"2.42"},{"date":"2026.08.20","price":"0.59","value":"-1.50"},{"date":"2026.08.19","price":"-5.01","value":"-1.04"},{"date":"2026.08.18","price":"-0.56","value":"0.49"},{"date":"2026.08.17","price":"2.44","value":"-0.81"},{"date":"2026.08.14","price":"0.45","value":"1.59"},{"date":"2026.08.13","price":"-0.87","value":"0.14"},{"date":"2026.08.12","price":"1.09","value":"0.34"},{"date":"2026.08.11","price":"-0.40","value":"0.39"},{"date":"2026.08.10","price":"0.04","value":"2.10"},{"date":"2026.08.07","price":"1.42","value":"0.32"},{"date":"2026.08.06","price":"-0.24","value":"-0.59"},{"date":"2026.08.05","price":"1.86","value":"0.61"}]
深证成指,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 汉森制药 | 46.57% | -21.62% | 5.8分 |
| 2 | 千金药业 | 33.20% | 17.60% | 6.0分 |
| 3 | 精华制药 | 19.61% | 13.01% | 5.4分 |
| 4 | 方盛制药 | 17.88% | 9.54% | 6.2分 |
| 5 | 沃华医药 | 17.25% | 10.47% | 6.2分 |
| 6 | 粤万年青 | 16.53% | 3.07% | 4.5分 |
| 8 | 古汉医药 | 11.74% | 0.63% | 5.9分 |
| 10 | 益佰制药 | 11.52% | -2.70% | 5.4分 |
| 12 | 新天药业 | 10.51% | -0.69% | 6.4分 |
| 14 | 益盛药业 | 10.08% | 1.43% | 6.1分 |
| 16 | 振东制药 | 9.54% | 5.15% | 5.5分 |
| 18 | 新光药业 | 6.28% | -2.93% | 4.9分 |
| 20 | 康惠股份 | 6.18% | 8.10% | 5.1分 |
| 22 | 恩威医药 | 4.55% | -1.04% | 5.3分 |
| 24 | 信邦制药 | 4.08% | -1.29% | 6.0分 |
| 26 | 康恩贝 | 3.50% | -0.23% | 6.2分 |
| 28 | 中恒集团 | 2.71% | -1.73% | 5.2分 |
| 30 | 寿仙谷 | 1.84% | 1.02% | 4.9分 |
| 32 | 康美药业 | 1.46% | 0.00% | 5.5分 |
| 34 | 亚宝药业 | 0.59% | -5.16% | 5.6分 |
| 36 | ST金花 | 0.00% | 1.03% | 5.5分 |
| 38 | 陇神戎发 | -0.37% | -20.89% | 4.4分 |
| 40 | 九芝堂 | -0.44% | 0.33% | 6.2分 |
| 42 | 红日药业 | -1.47% | -2.62% | 5.1分 |
| 44 | 特一药业 | -2.18% | 1.24% | 5.4分 |
| 46 | 上海凯宝 | -2.70% | -5.43% | 4.4分 |
| 48 | 达仁堂 | -3.86% | -1.97% | 5.8分 |
| 50 | 步长制药 | -4.20% | -4.32% | 5.0分 |
| 52 | 济川药业 | -4.58% | -0.04% | 5.9分 |
| 54 | 同仁堂 | -4.94% | -2.49% | 5.0分 |
| 56 | 桂林三金 | -5.63% | 0.00% | 5.7分 |
| 58 | 天士力 | -6.93% | -0.95% | 5.7分 |
| 60 | 片仔癀 | -10.18% | -3.53% | 5.4分 |
| 62 | 葵花药业 | -10.73% | -10.67% | 4.9分 |
| 64 | 众生药业 | -11.23% | -0.77% | 5.6分 |
| 66 | 羚锐制药 | -12.77% | -0.46% | 6.2分 |
| 68 | 珍宝岛 | -13.79% | 0.35% | 4.8分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-06-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 14/109 ， 1/109。
[{"date":"2026-06-30","value":"7.39","vol":"3.25"},{"date":"2026-03-31","value":"1.91","vol":"2.21"},{"date":"2025-12-31","value":"14.39","vol":"-2.33"},{"date":"2025-09-30","value":"9.55","vol":"4.80"},{"date":"2025-06-30","value":"8.85","vol":"4.03"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
7.39 | 1.91 | 14.39 | 9.55 | 8.85 |
| 行业(%) | 3.25 | 2.21 | -2.33 | 4.80 | 4.03 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"82.08","vol":"53.70"},{"date":"2026-03-31","value":"83.93","vol":"55.05"},{"date":"2025-12-31","value":"83.05","vol":"52.85"},{"date":"2025-09-30","value":"82.25","vol":"53.29"},{"date":"2025-06-30","value":"82.19","vol":"53.82"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
82.08 | 83.93 | 83.05 | 82.25 | 82.19 |
| 行业(%) | 53.70 | 55.05 | 52.85 | 53.29 | 53.82 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 50/109 ， 27/109。
[{"date":"2026-06-30","value":"-16.77","vol":"-9.08"},{"date":"2026-03-31","value":"0.56","vol":"-5.58"},{"date":"2025-12-31","value":"3.34","vol":"-6.76"},{"date":"2025-09-30","value":"3.48","vol":"-7.84"},{"date":"2025-06-30","value":"16.36","vol":"-7.78"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-16.77 | 0.56 | 3.34 | 3.48 | 16.36 |
| 行业(%) | -9.08 | -5.58 | -6.76 | -7.84 | -7.78 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"3.60","vol":"-101.51"},{"date":"2026-03-31","value":"25.77","vol":"1.06"},{"date":"2025-12-31","value":"11.36","vol":"-80.25"},{"date":"2025-09-30","value":"7.66","vol":"-2.78"},{"date":"2025-06-30","value":"10.04","vol":"2.25"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
3.60 | 25.77 | 11.36 | 7.66 | 10.04 |
| 行业(%) | -101.51 | 1.06 | -80.25 | -2.78 | 2.25 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 52/109 ， 53/109。
[{"date":"2026-06-30","value":"0.14","vol":"0.22"},{"date":"2026-03-31","value":"0.06","vol":"0.12"},{"date":"2025-12-31","value":"0.35","vol":"0.47"},{"date":"2025-09-30","value":"0.23","vol":"0.35"},{"date":"2025-06-30","value":"0.17","vol":"0.24"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.14 | 0.06 | 0.35 | 0.23 | 0.17 |
| 行业(次) | 0.22 | 0.12 | 0.47 | 0.35 | 0.24 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.56","vol":"1.14"},{"date":"2026-03-31","value":"0.21","vol":"0.59"},{"date":"2025-12-31","value":"1.71","vol":"2.34"},{"date":"2025-09-30","value":"1.16","vol":"1.72"},{"date":"2025-06-30","value":"1.07","vol":"1.17"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.56 | 0.21 | 1.71 | 1.16 | 1.07 |
| 行业(次) | 1.14 | 0.59 | 2.34 | 1.72 | 1.17 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 4/109 ， 48/109。
[{"date":"2026-06-30","value":"70.36","vol":"20.65"},{"date":"2026-03-31","value":"-40.34","vol":"5.83"},{"date":"2025-12-31","value":"25.44","vol":"30.77"},{"date":"2025-09-30","value":"3.25","vol":"10.53"},{"date":"2025-06-30","value":"30.49","vol":"22.82"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 70.36 | -40.34 | 25.44 | 3.25 | 30.49 |
| 行业 | 20.65 | 5.83 | 30.77 | 10.53 | 22.82 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.97","vol":"0.88"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.07","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.89","vol":"1.03"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.97 | - | 1.07 | - | 0.89 |
| 行业 | 0.88 | 0.00 | 1.00 | 0.00 | 1.03 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 34/109 ， 46/109。
[{"date":"2026-06-30","value":"2.99","vol":"3.10"},{"date":"2026-03-31","value":"3.12","vol":"2.97"},{"date":"2025-12-31","value":"2.57","vol":"2.94"},{"date":"2025-09-30","value":"2.63","vol":"3.09"},{"date":"2025-06-30","value":"2.53","vol":"2.94"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.99 | 3.12 | 2.57 | 2.63 | 2.53 |
| 行业 | 3.10 | 2.97 | 2.94 | 3.09 | 2.94 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"2.63","vol":"2.34"},{"date":"2026-03-31","value":"2.71","vol":"2.23"},{"date":"2025-12-31","value":"2.30","vol":"2.15"},{"date":"2025-09-30","value":"2.39","vol":"2.24"},{"date":"2025-06-30","value":"2.36","vol":"2.15"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.63 | 2.71 | 2.30 | 2.39 | 2.36 |
| 行业 | 2.34 | 2.23 | 2.15 | 2.24 | 2.15 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 40/109 ， 43/109。
[{"date":"2026-06-30","value":"23.55","vol":"32.07"},{"date":"2026-03-31","value":"23.56","vol":"31.94"},{"date":"2025-12-31","value":"27.77","vol":"32.43"},{"date":"2025-09-30","value":"26.92","vol":"31.59"},{"date":"2025-06-30","value":"40.16","vol":"32.45"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
23.55 | 23.56 | 27.77 | 26.92 | 40.16 |
| 行业(%) | 32.07 | 31.94 | 32.43 | 31.59 | 32.45 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.31","vol":"0.68"},{"date":"2026-03-31","value":"0.31","vol":"0.66"},{"date":"2025-12-31","value":"0.39","vol":"0.67"},{"date":"2025-09-30","value":"0.37","vol":"0.76"},{"date":"2025-06-30","value":"0.68","vol":"0.75"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.31 | 0.31 | 0.39 | 0.37 | 0.68 |
| 行业(%) | 0.68 | 0.66 | 0.67 | 0.76 | 0.75 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"4.72","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"5.81","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"5.82","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"6.48","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]